![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Grassley Calls for Drugmakers to Share Medicare Costs
Grassley Calls for Drugmakers to Share Medicare Costs
![100Bills_flatmoney.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/100Bills_flatmoney.gif?t=1578960048&width=430)
June 12, 2019
Drugmakers should contribute to Medicare’s catastrophic costs, says Senate Finance Committee Chairman Chuck Grassley.
The public pays 80 percent of catastrophic care under Medicare, Part D and Grassley, an Iowa Republican, said that it’s created “perverse incentives” for insurers and drug companies to get patients treated as such.
“Right now, there’s a big push to get thru the donut [hole] and get into catastrophic coverage, cause that’s where the taxpayer comes in,” he said, speaking at a forum hosted last week by Axios. “We want to take away that incentive by having the insurance companies and the pharmaceuticals pay a greater part of the cost, put a cap on what out of pocket expenses would be and save the taxpayers’ money in the process.”
Grassley said that he’s confident that a package of bills will get to the Senate floor this year that will bring some daylight into the nation’s drug pricing regimes.
Upcoming Events
-
21Oct